Resultats de la cerca - Guanlan Xu
- Mostrar 1 - 12 resultats de 12
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Serum miR-204 is an early biomarker of type 1 diabetes-associated pancreatic beta-cell loss per Guanlan Xu, Lance A. Thielen, Junqin Chen, Truman Grayson, Tiffany Grimes, S. Louis Bridges, Hubert M. Tse, A. Blair Smith, Rakesh P. Patel, Peng Li, Carmella Evans‐Molina, Fernando Ovalle, Anath Shalev
Publicat 2019Artigo -
11
Exploratory study reveals far reaching systemic and cellular effects of verapamil treatment in subjects with type 1 diabetes per Guanlan Xu, Tiffany Grimes, Truman Grayson, Junqin Chen, Lance A. Thielen, Hubert M. Tse, Peng Li, Matt Kanke, Tai‐Tu Lin, Athena Schepmoes, Adam Swensen, Vladislav Petyuk, Fernando Ovalle, Praveen Sethupathy, Weijun Qian, Anath Shalev
Publicat 2022Artigo -
12
Identification of an Anti-diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action per Lance A. Thielen, Junqin Chen, Jing Gu, Omar Moukha‐Chafiq, Guanlan Xu, SEONGHO JO, Truman Grayson, Brian Lu, Peng Li, Corinne E. Augelli‐Szafran, Mark J. Suto, Matt Kanke, Praveen Sethupathy, Jason K. Kim, Anath Shalev
Publicat 2020Artigo
Eines de cerca:
Matèries relacionades
Biology
Endocrinology
Cell biology
Thioredoxin
Biochemistry
Diabetes mellitus
Gene
Medicine
TXNIP
Beta cell
Internal medicine
Islet
Thioredoxin-Interacting Protein
Cancer research
Chemistry
Oxidative stress
Apoptosis
Calcium
Cell
Genetics
Insulin
Metformin
Pharmacology
Signal transduction
Transcription factor
Type 2 diabetes
Verapamil
microRNA
BETA (programming language)
Computer science